Covered recipient · General Payments record
ROBERT G BONILLAS
Allopathic & Osteopathic Physicians Surgery Plastic and Reconstructive Surgery
General Payments · PY2018–2024
$5,735.47
- Reported across 75 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,324.51 | 21 |
| Travel and Lodging | $757.81 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $1,532.86 | 17 |
| Edwards Lifesciences Corporation | $160.82 | 1 |
| Novo Nordisk AS | $123.13 | 1 |
| Medtronic, Inc. | $118.29 | 1 |
| Phathom Pharmaceuticals, Inc. | $107.17 | 1 |
| REVANCE THERAPEUTICS, INC. | $40.05 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.19 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346452 | CMS |
| ABBVIE INC. | $30.96 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346454 | CMS |
| ABBVIE INC. | $68.60 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346456 | CMS |
| ABBVIE INC. | $7.43 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346458 | CMS |
| ABBVIE INC. | $1.89 | 09/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346460 | CMS |
| ABBVIE INC. | $15.22 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346462 | CMS |
| ABBVIE INC. | $19.69 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346464 | CMS |
| ABBVIE INC. | $22.09 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346466 | CMS |
| ABBVIE INC. | $63.53 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346468 | CMS |
| ABBVIE INC. | $69.55 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346470 | CMS |
| ABBVIE INC. | $86.28 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346472 | CMS |
| ABBVIE INC. | $98.23 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346474 | CMS |
| ABBVIE INC. | $245.11 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346476 | CMS |
| ABBVIE INC. | $447.85 | 11/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104178094 | CMS |
| ABBVIE INC. | $309.96 | 11/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104178096 | CMS |
| ABBVIE INC. | $24.50 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346478 | CMS |
| ABBVIE INC. | $4.78 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346480 | CMS |
| Edwards Lifesciences Corporation | $160.82 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138863477 | CMS |
| Medtronic, Inc. | $118.29 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119395868 | CMS |
| Novo Nordisk Inc | $123.13 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097809281 | CMS |
| Phathom Pharmaceuticals, Inc. | $107.17 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151041857 | CMS |
| REVANCE THERAPEUTICS, INC. | $23.10 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147913187 | CMS |
| REVANCE THERAPEUTICS, INC. | $16.95 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147913189 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.